Hepatocellular carcinoma: an overview (Q38876753)

7 September 2017

title

Hepatocellular carcinoma: an overview (English)

1 reference

7 September 2017

main subject

hepatocellular carcinoma

1 reference

Anthony PP

1

1 reference

7 September 2017

publication date

1 August 2001

1 reference

7 September 2017

1 reference

7 September 2017

volume

39

1 reference

7 September 2017

issue

2

1 reference

7 September 2017

page(s)

109-118

1 reference

Epidemiology of primary liver cancer

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Hepatitis B vaccination and hepatocellular carcinoma in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Modeling the hepatitis C virus epidemic in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Hepatitis B virus infection and hepatocellular carcinoma: molecular genetics and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Hepatitis B virus X protein: structure, function and biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Hepatitis B virus X protein: searching for a role in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Molecular basis of multistep hepatocarcinogenesis: genetic and epigenetic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Hepatitis C virus and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

The hepatitis C virus: overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

HCV-associated liver cancer without cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

HCV-associated hepatocellular carcinoma without cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Detection and analysis of replicating hepatitis C virus RNA in hepatocellular carcinoma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Hepatitis G virus: identification, prevalence and unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

TT virus--highly prevalent, but still in search of a disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Hepatocellular carcinoma, alcohol, and cirrhosis: facts and hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Maintenance immunosuppression after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

p53 mutation in hepatocellular carcinoma after aflatoxin exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Disorders of iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Is high AgNOR quantity in hepatocytes associated with increased risk of hepatocellular carcinoma in chronic liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Apoptosis and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Large regenerative nodules and dysplastic nodules in cirrhotic livers: a histopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Hepatic microvasculature: dynamic structure and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Liver cell dysplasia: a premalignant condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.2001.01188.X

10.1046/J.1365-2559.2001.01188.X

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference